K2M commenced global launch of EVEREST® Minimally Invasive XTower™ instrumentation to support the EVEREST MI XT cannulated top-loading polyaxial pedicle screw system.
Interim results in a Phase IIA trial with Bone Therapeutics’ ALLOB® show evidence of successful spinal fusion and statistically significant improvements at 12 months.
Bioventus enrolled first patients in BONES, the Bioventus Observational Non-interventional EXOGEN® Studies program, investigating the mitigation of nonunion.